What is Bausch + Lomb's market cap?

Bausch + Lomb (BLCO) has a market capitalization of $5.8B and trades on NYSE.

What is Bausch + Lomb's revenue and profitability?

Bausch + Lomb generated $5.3B in trailing twelve-month revenue with a net loss of $171.0M, representing a net margin of -3.2%, with free cash flow of -$175.0M. These figures are based on the Q2 2026 filing.

Who are Bausch + Lomb's competitors?

Bausch + Lomb's key competitors include CooperCompanies, Johnson & Johnson, AbbVie, and others. These companies compete in similar markets and product categories.

Who does Bausch + Lomb partner with?

Bausch + Lomb's notable partners include Novaliq GmbH, National Eye Institute.

What subsidiaries does Bausch + Lomb have?

Bausch + Lomb's subsidiaries include Bausch Health Companies Inc..

Where is Bausch + Lomb headquartered?

Bausch + Lomb is headquartered in Canada and employs approximately 13,300 people. It has been publicly traded since 2022.

Bausch + Lomb

BLCO

Bausch + Lomb is a leading global eye health company that provides a comprehensive portfolio of products spanning the entire continuum of vision care.

Market cap

$5.8B+19.8%

Revenue$5.3B+8.9%

Net income-$171.0M+37.4%

Free cash flow-$175.0M-197%

EPS (diluted)-$0.49+37.2%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

July 29, 2026

Revenue$1.4BBeat by $24.8M EPS$0.15Miss by $0.00

Read the full report

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full

Revenue$1.4B+9.1%

Operating income$83.0M+855%

Net income-$14.0M+77.4%

EPS (diluted)-$0.04+77.8%

Balance sheet

See full

Cash & equivalents$378.0M+39.0%

Total debt$5.1B+2.4%

Total equity$6.4B-1.0%

Total assets$13.9B+0.2%

Cash flow

See full

Operating cash flow$153.0M+337%

CapEx$71.0M-20.2%

Free cash flow$82.0M+252%

Valuation & ratios

Valuation

See full

Market cap$5.8B+19.8%

Enterprise value$10.5B+7.3%

P/S1.1×0.0×

Profitability

See full

Operating margin6.1%+5.3pp

Net margin-3.2%-1.0pp

Returns & leverage

See full

Return on equity-2.7%-0.7pp

Debt / equity0.8×0.0×

Current ratio1.5×0.0×

Segments

By segment

See full

Vision Care$784.0M+4.1%

Pharmaceuticals$300.0M+15.4%

Surgical$256.0M+18.5%

By product

See full

Devices$524.0M+11.0%

OTC$497.0M+3.1%

Branded and Other Generics$68.0M+17.2%

Competitors

By market cap

Johnson & Johnson$640.91B+60.1%

AbbVie$453.91B+36.3%

Alcon$32.8B-26.4%

The Cooper Companies, Inc.$13.7B-5.8%

Bausch + Lomb$5.8B+13.7%

Ocular Therapeutix$1.9B-1.7%

Bausch Health Companies$1.7B-34.3%

HRO

Harrow$1.4B+9.1%

By revenue growth

HRO

Harrow+26.2%

AbbVie+9.5%

Bausch + Lomb+8.9%

Bausch Health Companies+8.2%

Johnson & Johnson+8.1%

The Cooper Companies, Inc.+6.1%

Ocular Therapeutix-12.8%

By net margin

Johnson & Johnson21.48%-3.5pp

AbbVie5.79%-1.5pp

The Cooper Companies, Inc.5.57%-4.8pp

Bausch Health Companies-1.88%-9.1pp

Bausch + Lomb-3.21%+2.4pp

HRO

Harrow-19.75%+1.0pp

Ocular Therapeutix-558.24%-235pp

Profile

Bausch + Lomb is a leading global eye health company that provides a comprehensive portfolio of products spanning the entire continuum of vision care. The company develops, manufactures, and markets a diverse range of contact lenses, ophthalmic pharmaceuticals, and surgical systems to treat conditions from birth through every phase of life. Its core value proposition centers on being a fully integrated eye health business with a significant global footprint and established brand equity.

Competitive position

A leading global eye health player with a fully integrated portfolio that covers the entire patient lifecycle and all major categories of the eye health market.

GeographiesGlobal, United States, Canada, Europe, Asia

Customer segmentsPatients, Healthcare Providers, Retail Consumers

Business modelManufacturing, Research and Development, Direct Sales, Licensing

SuppliersRaw material suppliers, Specialized chemical providers, Electronic component manufacturers for surgical systems, Licensing partners for drug candidates

CustomersRetail pharmacies, Optical retailers, Hospitals and surgical centers, Individual patients and consumers

CountryCanada

Listed2022

Employees13.3K

CEOBrenton L. Saunders

SectorHealthcare

IndustryMedical - Instruments & Supplies

Websitebausch.com

FilingsSEC EDGAR

Ask your AI about Bausch + Lomb.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch + Lomb's market cap?: Bausch + Lomb (BLCO) has a market capitalization of $5.8B and trades on NYSE.
What is Bausch + Lomb's revenue and profitability?: Bausch + Lomb generated $5.3B in trailing twelve-month revenue with a net loss of $171.0M, representing a net margin of -3.2%, with free cash flow of -$175.0M. These figures are based on the Q2 2026 filing.
Who are Bausch + Lomb's competitors?: Bausch + Lomb's key competitors include CooperCompanies, Johnson & Johnson, AbbVie, and others. These companies compete in similar markets and product categories.
Who does Bausch + Lomb partner with?: Bausch + Lomb's notable partners include Novaliq GmbH, National Eye Institute.
What subsidiaries does Bausch + Lomb have?: Bausch + Lomb's subsidiaries include Bausch Health Companies Inc..
Where is Bausch + Lomb headquartered?: Bausch + Lomb is headquartered in Canada and employs approximately 13,300 people. It has been publicly traded since 2022.